PRTG — Portage Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Portage Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.27	3.22	2.77	23.4	10.5
Net Total Accounts Receivable
Net Total Receivables	—	0.56	0.683	0.351	0.801
Prepaid Expenses
Total Current Assets	6.55	3.79	4.95	24.8	13.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	174	173	175	195	99.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.79	2.57	3.21	0.783	1.86
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	74	76.6	73.4	73.5	23.1
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	99.7	96.5	101	121	76
Total Liabilities & Shareholders' Equity	174	173	175	195	99.1
Total Common Shares Outstanding